Core Insights - Huami Technology (ZEPP.US) experienced a rapid stock price increase of over 48%, reaching a high of $19.26, the highest since March 2022, with a cumulative rise of over 550% in the past month [1] Financial Performance - For the second quarter ending June 30, 2025, the company reported a significant revenue growth of 46.2% year-over-year, exceeding previous guidance and marking the first overall revenue growth since 2021 [1] - The core brand Amazfit has been identified as the growth engine, with strong sales from the Bip 6 and Active 2 series, as well as robust performance from the high-end T-Rex 3 model. New products like the Balance 2 smartwatch and Helio wristband launched in June also contributed significantly [1] - The company reported a GAAP net loss of $7.7 million and an adjusted net loss of $6.16 million, representing a year-over-year reduction of 28.6% and 30.2% respectively, with a stable gross margin of 36.2% [1] Future Outlook - Management anticipates third-quarter revenue to reach between $72 million and $76 million, reflecting a year-over-year growth of 70% to 79% [1] - CEO Huang Wang stated that the current quarter marks the beginning of an upward cycle, supported by a rich pipeline of innovations that will sustain growth in the second half of the year and beyond, reinforcing Amazfit's leadership in the performance wearables sector [1]

Core Insights - Huami Technology (ZEPP.US) reported a significant revenue growth of 46.2% year-on-year for the second quarter ending June 30, 2025, marking the first overall revenue increase since 2021 [1] - The core brand Amazfit has become the growth engine, with strong sales from the Bip 6 and Active 2 series, and the high-end T-Rex 3 model performing well [1] - The company has narrowed its GAAP net loss to $7.7 million and adjusted net loss to $6.16 million, a reduction of 28.6% and 30.2% respectively compared to the same period last year, with a stable gross margin of 36.2% [1] Financial Performance - The financial health of the company continues to improve, with operating expenses decreasing quarter-on-quarter and cash reserves reaching $95.3 million at the end of the period [1] - The company strategically increased inventory to address new product launches and tariff risks while advancing a stock buyback plan to demonstrate long-term confidence [1] Strategic Initiatives - The strategic transformation has shown significant results, with Zepp focusing on building the Amazfit brand ecosystem and launching the AI-enabled Zepp OS 5.0 system [1] - Marketing efforts include signing NFL star Derrick Henry and utilizing multi-platform global marketing, resulting in a second-place brand progress ranking in the U.S. market during Amazon Prime membership days, and a 60% year-on-year sales increase in the EMEA region [1] Future Outlook - For the third quarter, management expects revenue to reach between $72 million and $76 million, representing a year-on-year growth of 70% to 79% [2] - The CEO indicated that this quarter marks the beginning of an upward cycle, supported by a rich pipeline of innovations to sustain growth in the second half of the year and beyond, solidifying Amazfit's leadership in the performance wearables sector [2]

Core Insights - Zepp Health Corporation reported a significant revenue growth of 46.2% year-over-year in Q2 2025, reaching US$59.4 million, marking its first overall revenue growth since 2021, primarily driven by Amazfit products [1][3][10] - The company expects continued strong performance in Q3 2025, projecting revenues between US$72.0 million and US$76.0 million, representing a year-over-year increase of approximately 70% to 79% [3][24] Financial Performance - Revenue for Q2 2025 was US$59.4 million, a 46.2% increase from Q2 2024 and a 54.2% increase from Q1 2025 [3][10] - The GAAP net loss narrowed to US$7.7 million in Q2 2025 from US$10.8 million in Q2 2024, while the adjusted net loss was US$6.16 million compared to US$8.8 million in the same period last year [3][18] - Gross margin remained stable at 36.2%, consistent with the previous quarter, but lower than Q2 2024 due to a higher proportion of lower-margin products [4][11] Product and Market Strategy - The company launched new products, including the Amazfit Balance 2 smartwatch and Helio Strap, which contributed positively to sales [2][3] - The Amazfit brand has seen enhanced global brand awareness, supported by a multi-tiered product strategy that resonates with diverse consumer groups [1][2] - The company has fostered a strong Amazfit Athletes team, now including notable sports figures, to enhance brand recognition and community engagement [1][2] Operational Efficiency - Total operating expenses for Q2 2025 were US$27.6 million, a 5.2% increase year-over-year, while adjusted operating expenses were US$26.4 million [4][16] - The company ended Q2 2025 with US$95.3 million in cash, indicating a stable capital structure and the ability to invest in future opportunities [6][19] Outlook - Management is optimistic about the second half of 2025, with a robust pipeline of innovations expected to drive sustained growth and value [1][2] - The company continues to manage working capital efficiently, with inventory strategically increased to prepare for upcoming product launches [20][21]

Core Insights - Zepp Health Corporation reported a 10% year-over-year growth in Amazfit revenue for Q1 2025, despite a challenging macroeconomic environment [1][3][6] - The company successfully launched new smartwatch models, Amazfit Active 2 and Bip 6, which have received positive market reception and are expected to drive further sales growth [1][2][6] - The management anticipates a year-over-year revenue increase for Q2 2025, projecting net revenues between US$50 million and US$55 million, representing a growth of approximately 23% to 35% compared to Q2 2024 [3][21] Financial Performance - Total revenue for Q1 2025 was US$39 million, with Amazfit-branded products growing by 10.2% year-over-year [3][6] - Gross margin improved to 37.3%, up from 36.8% in the same period last year, despite facing additional tariffs [3][7] - The net loss for Q1 2025 was US$19.7 million, compared to a net loss of US$14.8 million in Q1 2024 [15][33] Operating Expenses - Total operating expenses for Q1 2025 were US$32.7 million, a 6.9% increase year-over-year, driven by higher selling and marketing expenses [12][9] - Research and development expenses decreased by 7.8% year-over-year to US$12.4 million, reflecting a focus on resource efficiency [8] - Selling and marketing expenses rose by 28.5% year-over-year to US$13.8 million, primarily due to investments in digital campaigns and product launches [9][12] Cash and Debt Management - The company had a cash balance of US$104 million as of March 31, 2025, after repaying US$11.5 million in short-term debt [3][4] - Long-term borrowings now represent about 70% of total debt, with US$67.8 million of debt retired since early 2023 [4][18] - Improved working capital management contributed to a tighter cash conversion cycle, allowing for continued investment in growth opportunities [16][18] Market Strategy and Outlook - Zepp Health is committed to leveraging open-source technologies and enhancing AI capabilities to improve product offerings and user experience [2] - The company is expanding its brand presence through partnerships with athletes and community events, aiming to strengthen user connections and broaden its market reach [2][21] - Management remains focused on optimizing the supply chain and investing in AI-driven experiences to maintain leadership in the wearable market [2][21]